Uganda to receive 19,200 more doses of HIV prevention injectable drug amid struggle to keep up with demand
The Ministry of Health has announced that Uganda will receive an additional 19,200 doses of lenacapavir, a long-acting injectable medicine ...
The Ministry of Health has announced that Uganda will receive an additional 19,200 doses of lenacapavir, a long-acting injectable medicine ...
Uganda has started rolling out Lenacapavir, a long-acting injectable drug that helps prevent HIV, in selected health facilities across the ...
Uganda has received 19,200 doses of Lenacapavir, a new long-acting HIV prevention drug that is taken only twice a year ...
Uganda’s National Drug Authority (NDA) has approved Lenacapavir, a long-acting HIV prevention injection developed by US pharmaceutical company Gilead Sciences, ...
Minister of Health, Dr Jane Ruth Aceng, has welcomed a landmark global deal that will dramatically slash the cost of ...
The World Health Organization (WHO) has officially recommended the use of a newly approved HIV prevention drug, lenacapavir, marking a ...
Uganda is preparing to roll out Lenacapavir, a revolutionary HIV prevention injection that provides protection for six months and has ...
The US Food and Drug Administration (FDA) has approved lenacapavir for the prevention of HIV, marking a major milestone in ...
A groundbreaking trial called PURPOSE 1 has yielded remarkable results, offering a promising alternative to daily pills for HIV prevention. ...